“Four primary metabolites of bupropion, threo‐ and erythro‐hydrobupropion and R,R‐ and S,S‐OH‐bupropion, circulate at higher concentrations than the parent drug and are believed to contribute to the efficacy and side effects of bupropion as well as to the CYP2D6 inhibition.”